English  |  正體中文  |  简体中文  |  總筆數 :2818629  
造訪人次 :  28108304    線上人數 :  866
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"links m"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-8 / 8 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-26T09:26:53Z Impact of specific Epidermal Growth Factor Receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: A meta-analysis Chih-Hsin Yang;Gralla R.J;Gebski V;Links M;Pavlakis N;Rosell R;Mitsudomi T;Zhou C;Inoue A;Lord S.J;Ding P.N;Wu Y.-L;Lee C.K; Lee C.K; Wu Y.-L; Ding P.N; Lord S.J; Inoue A; Zhou C; Mitsudomi T; Rosell R; Pavlakis N; Links M; Gebski V; Gralla R.J; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:53Z Impact of specific Epidermal Growth Factor Receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: A meta-analysis Chih-Hsin Yang;Gralla R.J;Gebski V;Links M;Pavlakis N;Rosell R;Mitsudomi T;Zhou C;Inoue A;Lord S.J;Ding P.N;Wu Y.-L;Lee C.K; Lee C.K; Wu Y.-L; Ding P.N; Lord S.J; Inoue A; Zhou C; Mitsudomi T; Rosell R; Pavlakis N; Links M; Gebski V; Gralla R.J; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:39Z Checkpoint Inhibitors in Metastatic EGFR-Mutated Non?�Small Cell Lung Cancer?�A Meta-Analysis Chih-Hsin Yang;Mok T;Gebski V;Links M;Lord S;Man J;Lee C.K; Lee C.K; Man J; Lord S; Links M; Gebski V; Mok T; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:39Z Checkpoint Inhibitors in Metastatic EGFR-Mutated Non?�Small Cell Lung Cancer?�A Meta-Analysis Chih-Hsin Yang;Mok T;Gebski V;Links M;Lord S;Man J;Lee C.K; Lee C.K; Man J; Lord S; Links M; Gebski V; Mok T; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:38Z Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non?�Small Cell Lung Cancer Lee C.K.; CHIH-HSIN YANG; Gralla R.J; Bray V; Links M; Gebski V; Lord S.J; Lee C.K.;Chih-Hsin Yang;Gralla R.J;Bray V;Links M;Gebski V;Lord S.J;Ding P.N; Ding P.N
臺大學術典藏 2020-05-26T09:26:38Z Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non?�Small Cell Lung Cancer Lee C.K.; CHIH-HSIN YANG; Gralla R.J; Bray V; Links M; Gebski V; Lord S.J; Lee C.K.;Chih-Hsin Yang;Gralla R.J;Bray V;Links M;Gebski V;Lord S.J;Ding P.N; Ding P.N
臺大學術典藏 2020-05-26T09:26:31Z Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma: A systematic review and meta-analysis Chih-Hsin Yang;Mok T;Gralla R.J;Herbst R.S;Gebski V;Links M;Cooper W;Lord S;Man J;Lee C.K; Lee C.K; Man J; Lord S; Cooper W; Links M; Gebski V; Herbst R.S; Gralla R.J; Mok T; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:31Z Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma: A systematic review and meta-analysis Chih-Hsin Yang;Mok T;Gralla R.J;Herbst R.S;Gebski V;Links M;Cooper W;Lord S;Man J;Lee C.K; Lee C.K; Man J; Lord S; Cooper W; Links M; Gebski V; Herbst R.S; Gralla R.J; Mok T; CHIH-HSIN YANG

顯示項目 1-8 / 8 (共1頁)
1 
每頁顯示[10|25|50]項目